Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst R Dow

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Combinatorial Chemistry|November 12, 2002
Automated analysis of proton NMR spectra from combinatorial rapid parallel synthesis using self-organizing mapsSandeep Kalelkar, Ernst R Dow, John Grimes, et al.
Journal of Biomedical Informatics|February 3, 2011
Leveraging health social networking communities in translational researchYue W Webster, Ernst R Dow, Jacob Koehler, et al.
Expert Opinion on Drug Discovery|March 16, 2013
Integrating scientific data for drug discovery and development using the Life Sciences GridErnst R Dow, James B Hughes, Susie M Stephens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 21, 2024
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor BaricitinibRuna Kuley, Bhargavi Duvvuri, Sabeeha Hasnain, et al.
Nucleic Acids Research|July 22, 2004
Discovery of sequence motifs related to coexpression of genes using evolutionary computationGary B Fogel, Dana G Weekes, Gabor Varga, et al.
Biorxiv : the Preprint Server for Biology|July 4, 2025
Identification of a conserved RNA structure in the <i>TNFRSF1A</i> 3'UTR: Implications for post-transcriptional regulationVan S Tompkins, Warren B Rouse, Jibo Wang, et al.
NAR Genomics and Bioinformatics|January 20, 2022
Prediction and analysis of functional RNA structures within the integrative genomics viewerWarren B Rouse, Ryan J Andrews, Nicholas J Booher, et al.
Arthritis Research & Therapy|October 13, 2020
The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritisChristian S Thudium, Anne C Bay-Jensen, Suntara Cahya, et al.
The Lancet. Rheumatology|September 7, 2025
Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trialVenkatesh Krishnan, Stuart Y Keller, Christine Chew, et al.
The Journal of Investigative Dermatology|March 26, 2023
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical PsoriasisScott A Ochsner, Mesias Pedroza, Rudolf T Pillich, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Combinatorial Chemistry|November 12, 2002
Automated analysis of proton NMR spectra from combinatorial rapid parallel synthesis using self-organizing mapsSandeep Kalelkar, Ernst R Dow, John Grimes, et al.
Journal of Biomedical Informatics|February 3, 2011
Leveraging health social networking communities in translational researchYue W Webster, Ernst R Dow, Jacob Koehler, et al.
Expert Opinion on Drug Discovery|March 16, 2013
Integrating scientific data for drug discovery and development using the Life Sciences GridErnst R Dow, James B Hughes, Susie M Stephens, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 21, 2024
Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor BaricitinibRuna Kuley, Bhargavi Duvvuri, Sabeeha Hasnain, et al.
Nucleic Acids Research|July 22, 2004
Discovery of sequence motifs related to coexpression of genes using evolutionary computationGary B Fogel, Dana G Weekes, Gabor Varga, et al.
Biorxiv : the Preprint Server for Biology|July 4, 2025
Identification of a conserved RNA structure in the <i>TNFRSF1A</i> 3'UTR: Implications for post-transcriptional regulationVan S Tompkins, Warren B Rouse, Jibo Wang, et al.
NAR Genomics and Bioinformatics|January 20, 2022
Prediction and analysis of functional RNA structures within the integrative genomics viewerWarren B Rouse, Ryan J Andrews, Nicholas J Booher, et al.
Arthritis Research & Therapy|October 13, 2020
The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritisChristian S Thudium, Anne C Bay-Jensen, Suntara Cahya, et al.
The Lancet. Rheumatology|September 7, 2025
Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trialVenkatesh Krishnan, Stuart Y Keller, Christine Chew, et al.
The Journal of Investigative Dermatology|March 26, 2023
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical PsoriasisScott A Ochsner, Mesias Pedroza, Rudolf T Pillich, et al.
Pageof 3